Gene Therapy Clinical Trials for Genetic Cardiomyopathies –
Overview and Considerations
Date: Wednesday, June 19th, 2024
6:00 – 7:00 PM ET*
Join us to learn more about:
- What is a gene therapy clinical trial and how does it differ from other trials
- Phases of gene therapy trials in the US
- Potential Considerations & Support
- How to identify a clinical trial that’s right for you
- Overview of Lexeo’s gene therapy program for PKP2-arrhythmogenic cardiomyopathy
- Live Q&A
Speaker: Nilomi Shah, Medical Affairs and Patient Engagement Lead – Lexeo Therapeutics
Nilomi Shah is the Medical Affairs and Patient Engagement Lead at Lexeo Therapeutics. Nilomi has 10 years of experience working in Medical Affairs and has supported development of various gene therapy candidates for the last 5 years. Nilomi received her Doctorate of Pharmacy from the Ernest Mario School of Pharmacy in 2014.
We hope you will join us for this event.
Click HERE to register.
Can’t attend live? Register to receive the webinar recording…
Note: This is the next in a series of webinars about gene therapy. To view the prior webinar, entitled Understanding Genetic Therapies for Cardiomyopathy – Our Hope for the Future, please click here. This content may be helpful to watch in advance of this June webinar.
To view archived webinars, please CLICK HERE.